Global Injectable Pain Medication Market Growth (Status and Outlook) 2025-2031

September 2025 | 82 pages | ID: GCCD83192A7CEN
LP Information

Abstracts

According to this study, the global Injectable Pain Medication market size will reach US$ million by 2031.

Analgesics refer to drugs that can partially or completely relieve pain. There are two types of non-steroidal anti-inflammatory drugs and central analgesics. The latter is currently mainly used in the treatment of cancer pain, and can also be used for short-term postoperative pain relief.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Injectable Pain Medication Industry Forecast” looks at past sales and reviews total world Injectable Pain Medication sales in 2024, providing a comprehensive analysis by region and market sector of projected Injectable Pain Medication sales for 2025 through 2031. With Injectable Pain Medication sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Injectable Pain Medication industry.

This Insight Report provides a comprehensive analysis of the global Injectable Pain Medication landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Injectable Pain Medication portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Injectable Pain Medication market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Injectable Pain Medication and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Injectable Pain Medication.

This report presents a comprehensive overview, market shares, and growth opportunities of Injectable Pain Medication market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
• Central Analgesics

Segmentation by Application:

• Hospital
• Clinics
• Recovery Center

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• GlaxoSmithKline
• Merck
• Pfizer
• Novartis
• Sanofi
• Bayer
• Johson & Johson
• Boehringer Ingelheim
• Sun Pharmaceutical

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Injectable Pain Medication Market Size (2020-2031)
  2.1.2 Injectable Pain Medication Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Injectable Pain Medication by Country/Region (2020, 2024 & 2031)
2.2 Injectable Pain Medication Segment by Type
  2.2.1 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
  2.2.2 Central Analgesics
2.3 Injectable Pain Medication Market Size by Type
  2.3.1 Injectable Pain Medication Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Injectable Pain Medication Market Size Market Share by Type (2020-2025)
2.4 Injectable Pain Medication Segment by Application
  2.4.1 Hospital
  2.4.2 Clinics
  2.4.3 Recovery Center
2.5 Injectable Pain Medication Market Size by Application
  2.5.1 Injectable Pain Medication Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Injectable Pain Medication Market Size Market Share by Application (2020-2025)

3 INJECTABLE PAIN MEDICATION MARKET SIZE BY PLAYER

3.1 Injectable Pain Medication Market Size Market Share by Player
  3.1.1 Global Injectable Pain Medication Revenue by Player (2020-2025)
  3.1.2 Global Injectable Pain Medication Revenue Market Share by Player (2020-2025)
3.2 Global Injectable Pain Medication Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 INJECTABLE PAIN MEDICATION BY REGION

4.1 Injectable Pain Medication Market Size by Region (2020-2025)
4.2 Global Injectable Pain Medication Annual Revenue by Country/Region (2020-2025)
4.3 Americas Injectable Pain Medication Market Size Growth (2020-2025)
4.4 APAC Injectable Pain Medication Market Size Growth (2020-2025)
4.5 Europe Injectable Pain Medication Market Size Growth (2020-2025)
4.6 Middle East & Africa Injectable Pain Medication Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Injectable Pain Medication Market Size by Country (2020-2025)
5.2 Americas Injectable Pain Medication Market Size by Type (2020-2025)
5.3 Americas Injectable Pain Medication Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Injectable Pain Medication Market Size by Region (2020-2025)
6.2 APAC Injectable Pain Medication Market Size by Type (2020-2025)
6.3 APAC Injectable Pain Medication Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Injectable Pain Medication Market Size by Country (2020-2025)
7.2 Europe Injectable Pain Medication Market Size by Type (2020-2025)
7.3 Europe Injectable Pain Medication Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Injectable Pain Medication by Region (2020-2025)
8.2 Middle East & Africa Injectable Pain Medication Market Size by Type (2020-2025)
8.3 Middle East & Africa Injectable Pain Medication Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL INJECTABLE PAIN MEDICATION MARKET FORECAST

10.1 Global Injectable Pain Medication Forecast by Region (2026-2031)
  10.1.1 Global Injectable Pain Medication Forecast by Region (2026-2031)
  10.1.2 Americas Injectable Pain Medication Forecast
  10.1.3 APAC Injectable Pain Medication Forecast
  10.1.4 Europe Injectable Pain Medication Forecast
  10.1.5 Middle East & Africa Injectable Pain Medication Forecast
10.2 Americas Injectable Pain Medication Forecast by Country (2026-2031)
  10.2.1 United States Market Injectable Pain Medication Forecast
  10.2.2 Canada Market Injectable Pain Medication Forecast
  10.2.3 Mexico Market Injectable Pain Medication Forecast
  10.2.4 Brazil Market Injectable Pain Medication Forecast
10.3 APAC Injectable Pain Medication Forecast by Region (2026-2031)
  10.3.1 China Injectable Pain Medication Market Forecast
  10.3.2 Japan Market Injectable Pain Medication Forecast
  10.3.3 Korea Market Injectable Pain Medication Forecast
  10.3.4 Southeast Asia Market Injectable Pain Medication Forecast
  10.3.5 India Market Injectable Pain Medication Forecast
  10.3.6 Australia Market Injectable Pain Medication Forecast
10.4 Europe Injectable Pain Medication Forecast by Country (2026-2031)
  10.4.1 Germany Market Injectable Pain Medication Forecast
  10.4.2 France Market Injectable Pain Medication Forecast
  10.4.3 UK Market Injectable Pain Medication Forecast
  10.4.4 Italy Market Injectable Pain Medication Forecast
  10.4.5 Russia Market Injectable Pain Medication Forecast
10.5 Middle East & Africa Injectable Pain Medication Forecast by Region (2026-2031)
  10.5.1 Egypt Market Injectable Pain Medication Forecast
  10.5.2 South Africa Market Injectable Pain Medication Forecast
  10.5.3 Israel Market Injectable Pain Medication Forecast
  10.5.4 Turkey Market Injectable Pain Medication Forecast
10.6 Global Injectable Pain Medication Forecast by Type (2026-2031)
10.7 Global Injectable Pain Medication Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Injectable Pain Medication Forecast

11 KEY PLAYERS ANALYSIS

11.1 GlaxoSmithKline
  11.1.1 GlaxoSmithKline Company Information
  11.1.2 GlaxoSmithKline Injectable Pain Medication Product Offered
  11.1.3 GlaxoSmithKline Injectable Pain Medication Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 GlaxoSmithKline Main Business Overview
  11.1.5 GlaxoSmithKline Latest Developments
11.2 Merck
  11.2.1 Merck Company Information
  11.2.2 Merck Injectable Pain Medication Product Offered
  11.2.3 Merck Injectable Pain Medication Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Merck Main Business Overview
  11.2.5 Merck Latest Developments
11.3 Pfizer
  11.3.1 Pfizer Company Information
  11.3.2 Pfizer Injectable Pain Medication Product Offered
  11.3.3 Pfizer Injectable Pain Medication Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Pfizer Main Business Overview
  11.3.5 Pfizer Latest Developments
11.4 Novartis
  11.4.1 Novartis Company Information
  11.4.2 Novartis Injectable Pain Medication Product Offered
  11.4.3 Novartis Injectable Pain Medication Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Novartis Main Business Overview
  11.4.5 Novartis Latest Developments
11.5 Sanofi
  11.5.1 Sanofi Company Information
  11.5.2 Sanofi Injectable Pain Medication Product Offered
  11.5.3 Sanofi Injectable Pain Medication Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Sanofi Main Business Overview
  11.5.5 Sanofi Latest Developments
11.6 Bayer
  11.6.1 Bayer Company Information
  11.6.2 Bayer Injectable Pain Medication Product Offered
  11.6.3 Bayer Injectable Pain Medication Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Bayer Main Business Overview
  11.6.5 Bayer Latest Developments
11.7 Johson & Johson
  11.7.1 Johson & Johson Company Information
  11.7.2 Johson & Johson Injectable Pain Medication Product Offered
  11.7.3 Johson & Johson Injectable Pain Medication Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Johson & Johson Main Business Overview
  11.7.5 Johson & Johson Latest Developments
11.8 Boehringer Ingelheim
  11.8.1 Boehringer Ingelheim Company Information
  11.8.2 Boehringer Ingelheim Injectable Pain Medication Product Offered
  11.8.3 Boehringer Ingelheim Injectable Pain Medication Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Boehringer Ingelheim Main Business Overview
  11.8.5 Boehringer Ingelheim Latest Developments
11.9 Sun Pharmaceutical
  11.9.1 Sun Pharmaceutical Company Information
  11.9.2 Sun Pharmaceutical Injectable Pain Medication Product Offered
  11.9.3 Sun Pharmaceutical Injectable Pain Medication Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Sun Pharmaceutical Main Business Overview
  11.9.5 Sun Pharmaceutical Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Injectable Pain Medication Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Injectable Pain Medication Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
Table 4. Major Players of Central Analgesics
Table 5. Injectable Pain Medication Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Injectable Pain Medication Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Injectable Pain Medication Market Size Market Share by Type (2020-2025)
Table 8. Injectable Pain Medication Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Injectable Pain Medication Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Injectable Pain Medication Market Size Market Share by Application (2020-2025)
Table 11. Global Injectable Pain Medication Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Injectable Pain Medication Revenue Market Share by Player (2020-2025)
Table 13. Injectable Pain Medication Key Players Head office and Products Offered
Table 14. Injectable Pain Medication Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Injectable Pain Medication Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Injectable Pain Medication Market Size Market Share by Region (2020-2025)
Table 19. Global Injectable Pain Medication Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Injectable Pain Medication Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Injectable Pain Medication Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Injectable Pain Medication Market Size Market Share by Country (2020-2025)
Table 23. Americas Injectable Pain Medication Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Injectable Pain Medication Market Size Market Share by Type (2020-2025)
Table 25. Americas Injectable Pain Medication Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Injectable Pain Medication Market Size Market Share by Application (2020-2025)
Table 27. APAC Injectable Pain Medication Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Injectable Pain Medication Market Size Market Share by Region (2020-2025)
Table 29. APAC Injectable Pain Medication Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Injectable Pain Medication Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Injectable Pain Medication Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Injectable Pain Medication Market Size Market Share by Country (2020-2025)
Table 33. Europe Injectable Pain Medication Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Injectable Pain Medication Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Injectable Pain Medication Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Injectable Pain Medication Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Injectable Pain Medication Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Injectable Pain Medication
Table 39. Key Market Challenges & Risks of Injectable Pain Medication
Table 40. Key Industry Trends of Injectable Pain Medication
Table 41. Global Injectable Pain Medication Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Injectable Pain Medication Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Injectable Pain Medication Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Injectable Pain Medication Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. GlaxoSmithKline Details, Company Type, Injectable Pain Medication Area Served and Its Competitors
Table 46. GlaxoSmithKline Injectable Pain Medication Product Offered
Table 47. GlaxoSmithKline Injectable Pain Medication Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. GlaxoSmithKline Main Business
Table 49. GlaxoSmithKline Latest Developments
Table 50. Merck Details, Company Type, Injectable Pain Medication Area Served and Its Competitors
Table 51. Merck Injectable Pain Medication Product Offered
Table 52. Merck Injectable Pain Medication Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Merck Main Business
Table 54. Merck Latest Developments
Table 55. Pfizer Details, Company Type, Injectable Pain Medication Area Served and Its Competitors
Table 56. Pfizer Injectable Pain Medication Product Offered
Table 57. Pfizer Injectable Pain Medication Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Pfizer Main Business
Table 59. Pfizer Latest Developments
Table 60. Novartis Details, Company Type, Injectable Pain Medication Area Served and Its Competitors
Table 61. Novartis Injectable Pain Medication Product Offered
Table 62. Novartis Injectable Pain Medication Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Novartis Main Business
Table 64. Novartis Latest Developments
Table 65. Sanofi Details, Company Type, Injectable Pain Medication Area Served and Its Competitors
Table 66. Sanofi Injectable Pain Medication Product Offered
Table 67. Sanofi Injectable Pain Medication Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Sanofi Main Business
Table 69. Sanofi Latest Developments
Table 70. Bayer Details, Company Type, Injectable Pain Medication Area Served and Its Competitors
Table 71. Bayer Injectable Pain Medication Product Offered
Table 72. Bayer Injectable Pain Medication Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Bayer Main Business
Table 74. Bayer Latest Developments
Table 75. Johson & Johson Details, Company Type, Injectable Pain Medication Area Served and Its Competitors
Table 76. Johson & Johson Injectable Pain Medication Product Offered
Table 77. Johson & Johson Injectable Pain Medication Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Johson & Johson Main Business
Table 79. Johson & Johson Latest Developments
Table 80. Boehringer Ingelheim Details, Company Type, Injectable Pain Medication Area Served and Its Competitors
Table 81. Boehringer Ingelheim Injectable Pain Medication Product Offered
Table 82. Boehringer Ingelheim Injectable Pain Medication Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Boehringer Ingelheim Main Business
Table 84. Boehringer Ingelheim Latest Developments
Table 85. Sun Pharmaceutical Details, Company Type, Injectable Pain Medication Area Served and Its Competitors
Table 86. Sun Pharmaceutical Injectable Pain Medication Product Offered
Table 87. Sun Pharmaceutical Injectable Pain Medication Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Sun Pharmaceutical Main Business
Table 89. Sun Pharmaceutical Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Injectable Pain Medication Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Injectable Pain Medication Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Injectable Pain Medication Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Injectable Pain Medication Sales Market Share by Country/Region (2024)
Figure 8. Injectable Pain Medication Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Injectable Pain Medication Market Size Market Share by Type in 2024
Figure 10. Injectable Pain Medication in Hospital
Figure 11. Global Injectable Pain Medication Market: Hospital (2020-2025) & ($ millions)
Figure 12. Injectable Pain Medication in Clinics
Figure 13. Global Injectable Pain Medication Market: Clinics (2020-2025) & ($ millions)
Figure 14. Injectable Pain Medication in Recovery Center
Figure 15. Global Injectable Pain Medication Market: Recovery Center (2020-2025) & ($ millions)
Figure 16. Global Injectable Pain Medication Market Size Market Share by Application in 2024
Figure 17. Global Injectable Pain Medication Revenue Market Share by Player in 2024
Figure 18. Global Injectable Pain Medication Market Size Market Share by Region (2020-2025)
Figure 19. Americas Injectable Pain Medication Market Size 2020-2025 ($ millions)
Figure 20. APAC Injectable Pain Medication Market Size 2020-2025 ($ millions)
Figure 21. Europe Injectable Pain Medication Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Injectable Pain Medication Market Size 2020-2025 ($ millions)
Figure 23. Americas Injectable Pain Medication Value Market Share by Country in 2024
Figure 24. United States Injectable Pain Medication Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Injectable Pain Medication Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Injectable Pain Medication Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Injectable Pain Medication Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Injectable Pain Medication Market Size Market Share by Region in 2024
Figure 29. APAC Injectable Pain Medication Market Size Market Share by Type (2020-2025)
Figure 30. APAC Injectable Pain Medication Market Size Market Share by Application (2020-2025)
Figure 31. China Injectable Pain Medication Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Injectable Pain Medication Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Injectable Pain Medication Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Injectable Pain Medication Market Size Growth 2020-2025 ($ millions)
Figure 35. India Injectable Pain Medication Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Injectable Pain Medication Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Injectable Pain Medication Market Size Market Share by Country in 2024
Figure 38. Europe Injectable Pain Medication Market Size Market Share by Type (2020-2025)
Figure 39. Europe Injectable Pain Medication Market Size Market Share by Application (2020-2025)
Figure 40. Germany Injectable Pain Medication Market Size Growth 2020-2025 ($ millions)
Figure 41. France Injectable Pain Medication Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Injectable Pain Medication Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Injectable Pain Medication Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Injectable Pain Medication Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Injectable Pain Medication Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Injectable Pain Medication Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Injectable Pain Medication Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Injectable Pain Medication Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Injectable Pain Medication Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Injectable Pain Medication Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Injectable Pain Medication Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Injectable Pain Medication Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Injectable Pain Medication Market Size 2026-2031 ($ millions)
Figure 54. APAC Injectable Pain Medication Market Size 2026-2031 ($ millions)
Figure 55. Europe Injectable Pain Medication Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Injectable Pain Medication Market Size 2026-2031 ($ millions)
Figure 57. United States Injectable Pain Medication Market Size 2026-2031 ($ millions)
Figure 58. Canada Injectable Pain Medication Market Size 2026-2031 ($ millions)
Figure 59. Mexico Injectable Pain Medication Market Size 2026-2031 ($ millions)
Figure 60. Brazil Injectable Pain Medication Market Size 2026-2031 ($ millions)
Figure 61. China Injectable Pain Medication Market Size 2026-2031 ($ millions)
Figure 62. Japan Injectable Pain Medication Market Size 2026-2031 ($ millions)
Figure 63. Korea Injectable Pain Medication Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Injectable Pain Medication Market Size 2026-2031 ($ millions)
Figure 65. India Injectable Pain Medication Market Size 2026-2031 ($ millions)
Figure 66. Australia Injectable Pain Medication Market Size 2026-2031 ($ millions)
Figure 67. Germany Injectable Pain Medication Market Size 2026-2031 ($ millions)
Figure 68. France Injectable Pain Medication Market Size 2026-2031 ($ millions)
Figure 69. UK Injectable Pain Medication Market Size 2026-2031 ($ millions)
Figure 70. Italy Injectable Pain Medication Market Size 2026-2031 ($ millions)
Figure 71. Russia Injectable Pain Medication Market Size 2026-2031 ($ millions)
Figure 72. Egypt Injectable Pain Medication Market Size 2026-2031 ($ millions)
Figure 73. South Africa Injectable Pain Medication Market Size 2026-2031 ($ millions)
Figure 74. Israel Injectable Pain Medication Market Size 2026-2031 ($ millions)
Figure 75. Turkey Injectable Pain Medication Market Size 2026-2031 ($ millions)
Figure 76. Global Injectable Pain Medication Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Injectable Pain Medication Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Injectable Pain Medication Market Size 2026-2031 ($ millions)